HeartSciences (HSCS) Income towards Parent Company (2021 - 2026)

HeartSciences (HSCS) has 6 years of Income towards Parent Company data on file, last reported at -$2.0 million in Q1 2026.

• For the quarter ending Q1 2026, Income towards Parent Company rose 21.97% year-over-year to -$2.0 million; the trailing twelve-month figure through Jan 2026 stood at -$8.5 million (up 1.73% YoY), and the FY2025 full-year result was -$8.9 million, down 32.93% from the prior year.
• Income towards Parent Company for Q1 2026 stood at -$2.0 million, up from -$2.4 million in the prior quarter.
• Across five years, Income towards Parent Company topped out at -$1.2 million in Q1 2022 and bottomed at -$2.6 million in Q1 2025.
• The 5-year median for Income towards Parent Company is -$1.9 million (2024), against an average of -$1.9 million.
• The widest annual swing landed in 2022, when Income towards Parent Company slumped 109.25%; it then advanced 21.97% in 2026.
• A 5-year view of Income towards Parent Company shows it stood at -$1.8 million in 2022, then rose by 3.28% to -$1.7 million in 2023, then decreased by 20.26% to -$2.1 million in 2024, then retreated by 11.9% to -$2.4 million in 2025, then gained by 15.41% to -$2.0 million in 2026.
• The last three Income towards Parent Company figures came in at -$2.0 million (Q1 2026), -$2.4 million (Q4 2025), and -$2.1 million (Q3 2025), per Business Quant data.

Peer Comparison